A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 2 · Has a placebo group

Conditions studied: Glaucoma, Ocular Hypertension

In brief

A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT00538304

Run by

Allergan

People needed

222

Starts

2007-11-01

Expected to finish

2008-05-01

Last updated by the study team

2019-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic glaucoma or ocular hypertension
• IOP controlled on Xalatan

You may not qualify if…

• Uncontrolled medical conditions
• Known hypersensitivity to study medications

Where it is running

• Study site — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.